Drug Pricing

Blog

Read more about broken 340B program

340B Advocates Strike Back

There are many reasons why government programs fail to deliver on their intentions, regardless of how well meaning they may be. The rhetoric from too many 340B recipients exemplifies a primary obstacle: Reforms that are necessary to correct a program’s glaring flaws or its fundamental unsustainability are demagogued and labeled ...
Commentary

PBM Industry Shadowy, Congress Shines Much Needed Light

The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs. The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days. The House Energy and Commerce ...
Commentary

Imposing Price Controls Is Never The Answer

The Senate Health, Education, Labor, and Pensions (HELP) Committee is currently reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA), which is supposed to help us prepare for the next public health emergency. Never missing an opportunity to impose price controls on anything and everything, Senator Bernie Sanders (I-VT) wants to ...
Commentary

Democrats want to take medicinal price controls further

Senate Democrats Take One More Step Toward Socialized Medicine

It’s been less than a year since Democrats enacted the Inflation Reduction Act, which gives Medicare the power to set the prices of certain medicines. Those price controls have yet to go into effect. But Democrats already want more. They’ve introduced new legislation that would amp up those price controls ...
Commentary

Read the latest on drug price controls

Dems’ Drug Price Controls Would Mean Fewer Drugs And Fewer Jobs

Hundreds of lifesaving therapies will never be invented, and as many as 1.1 million jobs will be lost if Senate Democrats successfully expand their prescription drug price-fixing program, according to a major new study. The study, conducted by the research group Vital Transformation, modeled the effects of the SMART Prices Act. Sponsored ...
Drug Innovation

NEW BRIEF: Cash-Based Support Would Empower Vulnerable to Buy Private Health Insurance, Create More Effective Safety Net

Click to download the brief “Tens of millions are stuck in a flawed government-run healthcare system that provides sub-par care to patients, imposes huge taxpayer costs, and harms the broader healthcare system,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and the series author. “By providing cash-based ...
Commentary

Read the latest on the Inflation Reduction Act's drug pricing reforms

Merck Fighting for Rights, Market-based Health Care

Pharmaceutical giant Merck announced last week that it is taking the federal government to court over the Inflation Reduction Act’s drug pricing reforms. The lawsuit alleges that the law’s Medicare price negotiation program violates some of the most fundamental rights guaranteed by the U.S. Constitution. “This is not ‘negotiation,'” the company says ...
Commentary

Read how shoplifting effects pharmacy shortages

Pharmacies Keep Closing: Blame Shoplifting and Intentional Pharmacist Shortages

While local and national media outlets frequently report on food deserts, particularly in cities that lack sufficient grocery stores, there is one major shortage that goes largely unnoticed by the press: pharmacies. “Pharmacy deserts” pose a real threat, particularly for vulnerable populations. This is something I’ve seen firsthand. Last year, ...
Drug Pricing

Bill Smith – Rationing Medicine

Bill Smith of the Pioneer Institute in Massachusetts joins Wayne and Tim to discuss his important new book “Rationing Medicine”, which focuses on an obscure economic concept called QALYs – or quality adjusted life years. 
Commentary

New COVID-19 research is troubling

Gov’t Undermines Search for Heart Disease Treatments

New research into COVID-19 has revealed some troubling findings. Even mild cases can lead to lasting heart complications. Comparing test data collected before and after a group of patients in their mid-30s contracted mild cases of COVID, researchers noticed an increase in arterial stiffness and cardiovascular inflammation. That means they may face “a widespread ...
Blog

Read more about broken 340B program

340B Advocates Strike Back

There are many reasons why government programs fail to deliver on their intentions, regardless of how well meaning they may be. The rhetoric from too many 340B recipients exemplifies a primary obstacle: Reforms that are necessary to correct a program’s glaring flaws or its fundamental unsustainability are demagogued and labeled ...
Commentary

PBM Industry Shadowy, Congress Shines Much Needed Light

The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs. The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days. The House Energy and Commerce ...
Commentary

Imposing Price Controls Is Never The Answer

The Senate Health, Education, Labor, and Pensions (HELP) Committee is currently reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA), which is supposed to help us prepare for the next public health emergency. Never missing an opportunity to impose price controls on anything and everything, Senator Bernie Sanders (I-VT) wants to ...
Commentary

Democrats want to take medicinal price controls further

Senate Democrats Take One More Step Toward Socialized Medicine

It’s been less than a year since Democrats enacted the Inflation Reduction Act, which gives Medicare the power to set the prices of certain medicines. Those price controls have yet to go into effect. But Democrats already want more. They’ve introduced new legislation that would amp up those price controls ...
Commentary

Read the latest on drug price controls

Dems’ Drug Price Controls Would Mean Fewer Drugs And Fewer Jobs

Hundreds of lifesaving therapies will never be invented, and as many as 1.1 million jobs will be lost if Senate Democrats successfully expand their prescription drug price-fixing program, according to a major new study. The study, conducted by the research group Vital Transformation, modeled the effects of the SMART Prices Act. Sponsored ...
Drug Innovation

NEW BRIEF: Cash-Based Support Would Empower Vulnerable to Buy Private Health Insurance, Create More Effective Safety Net

Click to download the brief “Tens of millions are stuck in a flawed government-run healthcare system that provides sub-par care to patients, imposes huge taxpayer costs, and harms the broader healthcare system,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and the series author. “By providing cash-based ...
Commentary

Read the latest on the Inflation Reduction Act's drug pricing reforms

Merck Fighting for Rights, Market-based Health Care

Pharmaceutical giant Merck announced last week that it is taking the federal government to court over the Inflation Reduction Act’s drug pricing reforms. The lawsuit alleges that the law’s Medicare price negotiation program violates some of the most fundamental rights guaranteed by the U.S. Constitution. “This is not ‘negotiation,'” the company says ...
Commentary

Read how shoplifting effects pharmacy shortages

Pharmacies Keep Closing: Blame Shoplifting and Intentional Pharmacist Shortages

While local and national media outlets frequently report on food deserts, particularly in cities that lack sufficient grocery stores, there is one major shortage that goes largely unnoticed by the press: pharmacies. “Pharmacy deserts” pose a real threat, particularly for vulnerable populations. This is something I’ve seen firsthand. Last year, ...
Drug Pricing

Bill Smith – Rationing Medicine

Bill Smith of the Pioneer Institute in Massachusetts joins Wayne and Tim to discuss his important new book “Rationing Medicine”, which focuses on an obscure economic concept called QALYs – or quality adjusted life years. 
Commentary

New COVID-19 research is troubling

Gov’t Undermines Search for Heart Disease Treatments

New research into COVID-19 has revealed some troubling findings. Even mild cases can lead to lasting heart complications. Comparing test data collected before and after a group of patients in their mid-30s contracted mild cases of COVID, researchers noticed an increase in arterial stiffness and cardiovascular inflammation. That means they may face “a widespread ...
Scroll to Top